Search results
Apr 17, 2023 · TC Early Stage is prime networking real estate and offers multiple ways to connect with the people who can help you realize and/or support your goals. Who knows? You might find a co-founder...
- TechCrunch Early Stage 2024
All Events TechCrunch Early Stage 2024 Apr 25 Boston. All...
- TechCrunch Early Stage 2024
Apr 25, 2024 · All Events TechCrunch Early Stage 2024 Apr 25 Boston. All Events Overview News Agenda Speakers Side Events Attendee Portal TechCrunch Early Stage 2024. Boston; April 25, 2024. Where we’ll be ...
Jun 25, 2024 · High-level results from the ADJUVANT BR.31 Phase III trial, sponsored by the Canadian Cancer Trials Group (CCTG), showed Imfinzi (durvalumab) did not achieve statistical significance for the primary endpoint of disease-free survival (DFS) versus placebo in early-stage (IB-IIIA) non-small cell lung cancer (NSCLC) after complete tumour resection in patients whose tumours express PD-L1 on 25% or ...
Jun 25, 2024 · Durvalumab Extends Lives of People with Early-Stage Small Cell Lung Cancer. A clinical trial has shown that durvalumab (Imfinzi) helps people with limited-stage small cell lung cancer live longer. Durvalumab is already used to treat people with extensive-stage small cell lung cancer. The immunotherapy drug durvalumab (Imfinzi) helped people ...
5 days ago · 5 Canadian cancer research breakthroughs. Local research, global impact. Learn about Canada’s international effect on cancer care. When the Canadian Cancer Society (CCS) first began funding research in the 1940s, 25% of Canadians diagnosed with cancer survived at least 5 years after their diagnosis. Today, 64% will survive at least 5 years.
Mar 22, 2024 · At TC Early Stage, three lucky founders will present their pitch decks for 4 minutes each in front of a panel of expert judges, gaining invaluable insights to refine their approach. Previous...
6 days ago · A Dallas company has added another product to this market, and says it can detect cancer earlier than ever with a $1,500 blood test. Cancer Check Labs calls the test a "breakthrough" in early ...
